Clinical Trials
23 trialsNCT04777851 2026-03-09
REPLACE
Translational Research in Oncology
Phase 3 Terminated
NCT04732286 2025-05-08
A Study of Atezolizumab in Combination With Bevacizumab in Spanish Patients With Unresectable or Unsuitable for Locoregional Treatments Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy
Hoffmann-La Roche
Phase 3 Terminated
NCT03960008 2024-08-28
SBRTvsTACE
Lahey Clinic
Phase 3 Terminated
NCT02762266 2024-03-12
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Stanford University
Phase 3 Terminated
NCT00658593 2023-08-04
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Canadian Cancer Trials Group
Phase 3 Terminated
NCT03236649 2023-02-08
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
Beijing Shenogen Biomedical Co., Ltd
Phase 3 Terminated
NCT01402908 2022-06-23
PATRON
Cellxpert Biotechnology Corp.
Phase 3 Terminated
NCT01387932 2021-11-30
HiQuality
Merit Medical Systems, Inc.
Phase 3 Terminated
NCT01887717 2021-04-21
YES-P
Boston Scientific Corporation
Phase 3 Terminated
NCT02460991 2021-02-12
SOLACE
Boston Scientific Corporation
Phase 3 Terminated
NCT01821963 2020-09-24
Telaprevir Plus Standard of Care (SOC) in HCV Associated Hepatocellular Carcinoma (HCC)
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT02867280 2020-02-11
Sorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection
Sun Yat-sen University
Phase 3 Terminated
NCT01465464 2019-08-07
ORIENTAL
Taiho Pharmaceutical Co., Ltd.
Phase 3 Terminated
NCT01676194 2019-04-12
CATCH
Rennes University Hospital
Phase 3 Terminated
NCT02319200 2017-01-11
METFOVIR
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT01108705 2015-10-12
BRISK-APS
Bristol-Myers Squibb
Phase 3 Terminated
NCT01872988 2014-09-04
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Phase 3 Terminated
NCT00699374 2013-01-14
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
Pfizer
Phase 3 Terminated
NCT01009593 2012-09-10
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Abbott
Phase 3 Terminated
NCT00225290 2011-10-12
Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve
TTY Biopharm
Phase 3 Terminated
NCT00568308 2011-06-15
PATHWAY
Progen Pharmaceuticals
Phase 3 Terminated
NCT00470340 2011-05-05
GEMOXIAL
Assistance Publique - Hôpitaux de Paris
Phase 3 Terminated
NCT00355212 2006-07-25
Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Azienda Ospedaliera San Giovanni Battista
Phase 3 Terminated